Aurigene Oncology Reports Positive Phase 1 Data for AUR112
02 Dec 2025 //
BUSINESSWIRE
Aurigene Oncology Presents A-PROX Platform At AACR-NCI-EORTC
22 Oct 2025 //
BUSINESSWIRE
Aurigene reports Positive Ph 1 trial for CAR-T cell therapy in India
09 Oct 2024 //
PRESS RELEASE

Market Place
Sourcing Support